Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.

Qesseveur G, Petit AC, Nguyen HT, Dahan L, Colle R, Rotenberg S, Seif I, Robert P, David D, Guilloux JP, Gardier AM, Verstuyft C, Becquemont L, Corruble E, Guiard BP.

Neuropharmacology. 2016 Jun;105:142-153. doi: 10.1016/j.neuropharm.2015.12.022. Epub 2016 Jan 4.

PMID:
26764241
2.

Excess type I interferon signaling in the mouse seminiferous tubules leads to germ cell loss and sterility.

Satie AP, Mazaud-Guittot S, Seif I, Mahé D, He Z, Jouve G, Jégou B, Dejucq-Rainsford N.

J Biol Chem. 2011 Jul 1;286(26):23280-95. doi: 10.1074/jbc.M111.229120. Epub 2011 Apr 22.

3.

Preoperative washing cytology in the diagnosis of maxillary sinus lesions.

Daneshbod Y, Khademi B, Moemeni B, Seif I, Daneshbod K.

Acta Cytol. 2010 Mar-Apr;54(2):148-58.

PMID:
20391970
5.

Ondansetron and fluoxetine reduce sleep apnea in mice lacking monoamine oxidase A.

Real C, Seif I, Adrien J, Escourrou P.

Respir Physiol Neurobiol. 2009 Sep 30;168(3):230-8. doi: 10.1016/j.resp.2009.07.003. Epub 2009 Jul 15.

PMID:
19615472
6.

Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload.

Lairez O, Calise D, Bianchi P, Ordener C, Spreux-Varoquaux O, Guilbeau-Frugier C, Escourrou G, Seif I, Roncalli J, Pizzinat N, Galinier M, Parini A, Mialet-Perez J.

J Mol Cell Cardiol. 2009 Apr;46(4):587-95. doi: 10.1016/j.yjmcc.2008.12.017. Epub 2009 Jan 7.

PMID:
19162038
7.

Regional changes in the cholinergic system in mice lacking monoamine oxidase A.

Grailhe R, Cardona A, Even N, Seif I, Changeux JP, Cloëz-Tayarani I.

Brain Res Bull. 2009 Mar 30;78(6):283-9. doi: 10.1016/j.brainresbull.2008.12.004. Epub 2008 Dec 25.

PMID:
19111597
8.

Gap junction-mediated astrocytic networks in the mouse barrel cortex.

Houades V, Koulakoff A, Ezan P, Seif I, Giaume C.

J Neurosci. 2008 May 14;28(20):5207-17. doi: 10.1523/JNEUROSCI.5100-07.2008.

9.

Sleep apneas are increased in mice lacking monoamine oxidase A.

Real C, Popa D, Seif I, Callebert J, Launay JM, Adrien J, Escourrou P.

Sleep. 2007 Oct;30(10):1295-302.

10.

Effect of MAO A deficiency on different kinds of aggression and social investigation in mice.

Vishnivetskaya GB, Skrinskaya JA, Seif I, Popova NK.

Aggress Behav. 2007 Jan-Feb;33(1):1-6.

PMID:
17441000
11.

Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis.

Pchejetski D, Kunduzova O, Dayon A, Calise D, Seguelas MH, Leducq N, Seif I, Parini A, Cuvillier O.

Circ Res. 2007 Jan 5;100(1):41-9. Epub 2006 Dec 7.

PMID:
17158340
12.
13.

Monoamine oxidase A knockout mice exhibit impaired nicotine preference but normal responses to novel stimuli.

Agatsuma S, Lee M, Zhu H, Chen K, Shih JC, Seif I, Hiroi N.

Hum Mol Genet. 2006 Sep 15;15(18):2721-31. Epub 2006 Aug 7.

PMID:
16893910
14.

Aberrant accumulation of serotonin in dopaminergic neurons.

Mössner R, Simantov R, Marx A, Lesch KP, Seif I.

Neurosci Lett. 2006 Jun 19;401(1-2):49-54. Epub 2006 Apr 25.

PMID:
16638624
15.

Acquisition and extinction of a conditioned passive avoidance reflex in mice with genetic knockout of monoamine oxidase A.

Dubrovina NI, Popova NK, Gilinskii MA, Tomilenko RA, Seif I.

Neurosci Behav Physiol. 2006 May;36(4):335-9.

PMID:
16583159
16.

Serotonin catabolism and the formation and fate of 5-hydroxyindole thiazolidine carboxylic acid.

Squires LN, Jakubowski JA, Stuart JN, Rubakhin SS, Hatcher NG, Kim WS, Chen K, Shih JC, Seif I, Sweedler JV.

J Biol Chem. 2006 May 12;281(19):13463-70. Epub 2006 Mar 14.

17.
18.

Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient mice.

Anderson NJ, Seif I, Nutt DJ, Hudson AL, Robinson ES.

J Neurochem. 2006 Mar;96(6):1551-9. Epub 2006 Feb 10.

19.

Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice.

Mekontso-Dessap A, Brouri F, Pascal O, Lechat P, Hanoun N, Lanfumey L, Seif I, Benhaiem-Sigaux N, Kirsch M, Hamon M, Adnot S, Eddahibi S.

Circulation. 2006 Jan 3;113(1):81-9. Epub 2005 Dec 27.

PMID:
16380550
20.

MAO A knockout attenuates adrenocortical response to various kinds of stress.

Popova NK, Maslova LN, Morosova EA, Bulygina VV, Seif I.

Psychoneuroendocrinology. 2006 Feb;31(2):179-86. Epub 2005 Aug 19. Erratum in: Psychoneuroendocrinology. 2006 Sep;31(8):1027.

PMID:
16112493
21.

[Training and extinction of passive avoidance in mice lacking monoamine oxidase A].

Dubrovina NI, Popova NK, Gilinskiĭ MA, Tomilenko RA, Seĭf I.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2005 Mar-Apr;55(2):221-6. Russian.

PMID:
15895863
22.
23.

MAO(A) knockout mice are more susceptible to seizures but show reduced epileptogenesis.

Teskey GC, Radford KS, Seif I, Dyck RH.

Epilepsy Res. 2004 Mar;59(1):25-34.

PMID:
15135164
24.

Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice.

Maragos WF, Young KL, Altman CS, Pocernich CB, Drake J, Butterfield DA, Seif I, Holschneider DP, Chen K, Shih JC.

Neurochem Res. 2004 Apr;29(4):741-6.

PMID:
15098936
25.

Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.

Guiard BP, Przybylski C, Guilloux JP, Seif I, Froger N, De Felipe C, Hunt SP, Lanfumey L, Gardier AM.

J Neurochem. 2004 Apr;89(1):54-63.

26.

Influence of monoamines on differentiating gonadotropin-releasing hormone neurones in foetal mice.

Pronina T, Ugrumov M, Calas A, Seif I, Tramu G.

J Neuroendocrinol. 2003 Oct;15(10):925-32.

PMID:
12969236
27.
28.

Altered zincergic innervation of the developing primary somatosensory cortex in monoamine oxidase-A knockout mice.

Brown CE, Seif I, De Maeyer E, Dyck RH.

Brain Res Dev Brain Res. 2003 Apr 14;142(1):19-29.

PMID:
12694941
29.

Monoaminergic control of vasopressin and VIP expression in the mouse suprachiasmatic nucleus.

Vacher CM, Frétier P, Créminon C, Seif I, De Maeyer E, Calas A, Hardin-Pouzet H.

J Neurosci Res. 2003 Mar 15;71(6):791-801.

PMID:
12605405
30.

Effects of genetic depletion of monoamines on somatosensory cortical development.

Alvarez C, Vitalis T, Fon EA, Hanoun N, Hamon M, Seif I, Edwards R, Gaspar P, Cases O.

Neuroscience. 2002;115(3):753-64.

PMID:
12435414
31.
33.

Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model.

Proietti E, Bracci L, Puzelli S, Di Pucchio T, Sestili P, De Vincenzi E, Venditti M, Capone I, Seif I, De Maeyer E, Tough D, Donatelli I, Belardelli F.

J Immunol. 2002 Jul 1;169(1):375-83.

34.

Interactions between TrkB signaling and serotonin excess in the developing murine somatosensory cortex: a role in tangential and radial organization of thalamocortical axons.

Vitalis T, Cases O, Gillies K, Hanoun N, Hamon M, Seif I, Gaspar P, Kind P, Price DJ.

J Neurosci. 2002 Jun 15;22(12):4987-5000.

35.

Enhanced tumor development in mice lacking a functional type I interferon receptor.

Picaud S, Bardot B, De Maeyer E, Seif I.

J Interferon Cytokine Res. 2002 Apr;22(4):457-62.

PMID:
12034028
36.
37.

Altered presynaptic function in monoaminergic neurons of monoamine oxidase-A knockout mice.

Owesson CA, Hopwood SE, Callado LF, Seif I, McLaughlin DP, Stamford JA.

Eur J Neurosci. 2002 May;15(9):1516-22.

PMID:
12028362
38.

Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice.

Evrard A, Malagié I, Laporte AM, Boni C, Hanoun N, Trillat AC, Seif I, De Maeyer E, Gardier A, Hamon M, Adrien J.

Eur J Neurosci. 2002 Mar;15(5):841-51.

PMID:
11906526
39.

Developmental expression of monoamine oxidases A and B in the central and peripheral nervous systems of the mouse.

Vitalis T, Fouquet C, Alvarez C, Seif I, Price D, Gaspar P, Cases O.

J Comp Neurol. 2002 Jan 21;442(4):331-47.

PMID:
11793338
40.
41.

Behavioral characteristics of mice with genetic knockout of monoamine oxidase type A.

Popova NK, Skrinskaya YA, Amstislavskaya TG, Vishnivetskaya GB, Seif I, de Meier E.

Neurosci Behav Physiol. 2001 Nov-Dec;31(6):597-602.

PMID:
11766896
42.

Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B.

Holschneider DP, Chen K, Seif I, Shih JC.

Brain Res Bull. 2001 Nov 15;56(5):453-62. Review.

43.

Regional serotonin metabolism in the brain of transgenic mice lacking monoamine oxidase A.

Popova NK, Gilinsky MA, Amstislavskaya TG, Morosova EA, Seif I, De Maeyer E.

J Neurosci Res. 2001 Nov 1;66(3):423-7.

PMID:
11746359
44.

Knockout Corner: Knockout mice for monoamine oxidase A.

Seif I, De Maeyer E.

Int J Neuropsychopharmacol. 1999 Sep;2(3):241-243.

PMID:
11281992
45.

Ginkgo biloba abolishes aggression in mice lacking MAO A.

Shih JC, Chen K, Ridd MJ, Seif I.

Antioxid Redox Signal. 2000 Fall;2(3):467-71.

PMID:
11229360
46.

[Characteristics of behavior of knockout mice with genetic monoamine oxidase A deficiency].

Popova NK, Skrinskaia IuA, Amstislavskaia TG, Vishnivetskaia GB, Seif I, De Mayer E.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2000 Nov-Dec;50(6):991-8. Russian.

PMID:
11190099
47.

Altered behavior and alcohol tolerance in transgenic mice lacking MAO A: a comparison with effects of MAO A inhibitor clorgyline.

Popova NK, Vishnivetskaya GB, Ivanova EA, Skrinskaya JA, Seif I.

Pharmacol Biochem Behav. 2000 Dec;67(4):719-27.

PMID:
11166062
48.

Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice.

Salichon N, Gaspar P, Upton AL, Picaud S, Hanoun N, Hamon M, De Maeyer E, Murphy DL, Mossner R, Lesch KP, Hen R, Seif I.

J Neurosci. 2001 Feb 1;21(3):884-96.

49.

Differential regulation of adenosine A(1) and A(2A) receptors in serotonin transporter and monoamine oxidase A-deficient mice.

Mössner R, Albert D, Persico AM, Hennig T, Bengel D, Holtmann B, Schmitt A, Keller F, Simantov R, Murphy D, Seif I, Deckert J, Lesch KP.

Eur Neuropsychopharmacol. 2000 Dec;10(6):489-93.

PMID:
11115739
50.

Supplemental Content

Support Center